Conflict of Interest

Category archives for Conflict of Interest

Transparency, strength at the FDA

The Boston Globe, home town paper of  Senator Ted Kennedy, Chair of the Senate Health, Environment, Labor and Pensions Committee, ran two important commentaries on the FDA this week.  First was an editorial  yesterday strongly urging Congress to pass a strong FDA reform bill, including restricting financial conflicts of interests for advisory committee members. Today the…

One Mining Professor Responds

In a post last week entitled Mining Professors Oppose Mine Safety Bill, I invited the signatories of a letter opposing new mine safety legislation to disclose their financial ties to the mining industry (if any) or other related conflicts of interest.  A couple of days later, one of the letter’s signers, Larry Grayson, PhD of Penn State University, responded thoughtfully…

Remember back in May, when public health advocates sounded the alarm about the fact that EPA’s short list of nominees for its Science Advisory Board asbestos panel included scientists associated with product defense firms? As David Michaels explained, these firms are hired by corporations and trade associations to minimize government regulation, and scientists associated with…

Doctor Gifts and Drug Company Favors

By Peter Lurie, MD, MPH, Deputy Director, Public Citizen’s Health Research Group Dr. Lurie is a contributor to Public Citizen’s drug newsletter, available at www.worstpills.org. He will present testimony on state doctor gift disclosure laws before the Senate Special Committee on Aging on Wednesday, June 27, 2007.  This article originally appeared in the May 2007…

By David Michaels The National Football League, like many trade associations, has been disputing the long-term risks associated with employment in that industry. We’ve written about the league’s Committee on Mild Traumatic Brain Injury, supposedly independent but in fact dominated by individuals who work for NFL teams or the league itself. The Concussion Commission has…

By David Michaels Chris Cillizza of WashingtonPost.com’s The Fix blog reports that former U.S. Senator Fred Thompson (R-Tenn.) is “growing more and more serious about a run for president” – in fact, he’s chosen a “campaign manager in waiting.” Tom Collamore, a former vice president of public affairs at Altria, has been leading the behind-the…

Top Drug Regulator Sentenced to Death

By David Michaels The Chinese government has apparently recognized the importance of integrity in drug regulation. According to AP: China’s top drug regulator was sentenced to death on charges of corruption and negligence, state media said Tuesday, the latest development stemming from growing alarm over the country’s poor food-safety record.

The public (that’s you) have until May 24 to comments on EPA’s list of nominees for its Science Advisory Board panel on asbestos.  David Michaels has weighed in on this issue  and is submitting his comments today to EPA.  Another organization providing input is the Natural Resources Defense Council (NRDC).  Writing on behalf of NRDC, senior scientist Jennifer Sass…

By David Michaels Product Defense is a lucrative business. The scientists who own and operate these firms make sizable profits helping polluters and manufacturers of dangerous products stymie public health and environmental regulators. The companies, and the scientists, sell not just their scientific expertise, but their knowledge of and access to regulatory agencies. Hire me,…

By David Michaels Earlier this month, the National Institute of Health’s National Toxicology Program fired the contractor that had been running its Center for the Evaluation of Risks to Human Reproduction (CERHR) after environmental health advocates drew attention to the company’s chemical industry ties. (Go here to see previous posts.) Now, the Milwaukee Journal Sentinel…